Gregory Brittingham is an accomplished professional in the field of cell biology and biotechnology, with a PhD from New York University. They have held significant roles at various organizations, including Janssen, where they utilized single-cell RNA sequencing for research on pre-malignancies. Gregory has also served as a Startup Consultant at Endless Frontier Labs, contributing to the selection of life science and tech companies, and is currently the Director of Product at Immunai, focusing on product development in the biotech space. Their expertise encompasses areas such as gene editing, nanoparticle engineering, and market research, shaping innovative strategies in drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices